Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FOLZ, JOSEPH

NPI: 1881013647 · EVANSVILLE, IN 47715 · Pain Medicine Physician · NPI assigned 04/09/2014

$68K
Total Medicaid Paid
1,697
Total Claims
1,646
Beneficiaries
8
Codes Billed
2019-08
First Month
2024-07
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 214 $5K
2020 150 $4K
2021 238 $6K
2022 265 $2K
2023 134 $3K
2024 696 $47K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 245 233 $24K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 424 419 $20K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 235 228 $14K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 54 52 $4K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 306 296 $3K
80305 174 162 $1K
99490 Ccm add 20min 48 48 $779.96
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 211 208 $361.96